Pfizer

•

Channel • 7 Shows

Life Sciences

Life Sciences

Updated 15/12/2025
Life Sciences

Life Sciences

Updated weekly
Medicine

Medicine

Updated 17/09/2025
Life Sciences

Life Sciences

Monthly
Science Fiction

Science Fiction

Series
Life Sciences

Life Sciences

Updated 21/11/2023
Medicine

Medicine

Updated weekly

22/10/2025

The hidden challenges of multiple myeloma

In this episode our expert panel discuss multiple myeloma, exploring some of the challenges of the disease and progress being made to help patients in the UK. Our host Dr Ellie Cannon is joined by Dr Sophie Castell, CEO at Myeloma UK, and Colm Doody, Oncology Medical Director at Pfizer UK. PP-UNP-GBR-13445 / October 2025 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

22/10/2025

•

31 min
28/10/2025

Part 1 — The Case of the Missing Vaccine

Medical advancements don’t just spring up—they happen by building on decades of previous discoveries. Today, one of these advancements might be on the verge of another breakthrough. But what had to happen first for it to exist? In this episode, co-hosts Dr. Raven Baxter and Dr. Ronald Gamble explore how a vaccine candidate for a deadly, once-mysterious bacterial disease came to be. The story takes them from one doctor’s groundbreaking connection in the 70s, all the way to a real lab where vaccines are being developed today. Featured Guests: – Carol Baker, Pediatric Infectious Disease Specialist – Isis Kanevsky, Senior Director, Vaccines, Pfizer – Ksenia Krylova, Senior Director, Vaccines, Pfizer Dive into the episode here: 02:54 - Getting into the problem 05:11 - The basics of immunity and vaccine science 09:32 - What is a conjugate vaccine? 14:44 - Group B Strep: A case study 22:23 - Talking to a GBS pioneer 31:40 - A trip to the lab 43:08 - What's next, and closing thoughts Season 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios. Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

28/10/2025

•

49 min
04/11/2025

Part 2 — The Mighty, Multifaceted Molecule

The next frontier of medicine is focused on highly targeted drug therapies that could expand the possibilities of individualized patient care. Today, scientists are working on a particular type of molecule that could harness multiple capabilities and treat inflammatory and autoimmune diseases in ways never done before. In this episode, co-hosts Dr. Raven Baxter and Dr. Ronald Gamble explore how the latest advancements in antibody engineering led to multispecific antibodies—powerhouse molecules that can do the jobs of multiple drugs in one. They learn all about what it takes to assemble these antibodies and the impact they could make on patients—with a patient. Featured Guests: – Emma Guttman, Chair of the Department of Dermatology, Icahn School of Medicine at Mount Sinai – Amanda Lopez, Patient, Texas Ambassador for the National Eczema Association – Laird Bloom, Senior Director of Biomedicine Design, Pfizer – Thomas Wynn, Vice President of Discovery, Inflammation & Immunology, Pfizer Dive into the episode here: 1:12 - A metaphor for multispecific antibodies 4:08 - How do multispecific antibodies work? 10:39 - The history behind multispecific antibodies 16:29 - How are multispecific antibody drugs are made? 22:58 - An eczema expert on the potential of multispecific antibodies 29:30 - Amanda Lopez's eczema story 40:14 - What's next, and closing thoughts Season 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios. Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

04/11/2025

•

42 min
18/11/2025

Part 4 — From Discovery to Delivery: How Scientists Are Revolutionizing Cancer Treatment

In drug discovery and development, every part of the process matters. Scientists learn from every experiment and every observation. In fact, some of the most cutting-edge advancements in medicine are being dreamed up from findings uncovered in the past. In this episode, co-hosts Dr. Raven Baxter and Dr. Ronald Gamble dive deep into antibody drug conjugates, a groundbreaking modality that uses targeted antibody engineering to deliver potent chemotherapy directly to cancer-causing cells. They explore the complex ADC creation process and learn how ADCs are changing the standard of care for bladder cancer, from someone with a personal relationship to the disease. Featured Guests: – Renee Barron-Gores, Caregiver – Phoenix Ho, Vice President, Oncology Early Clinical Development, Pfizer – Sharsti Sandall, Executive Director, ADC Biology, Oncology Research Unit, Pfizer Dive into the episode here: 1:16 - Old ideas yield new discoveries 3:01 - How do antibody drug conjugates work? 5:07 - The origins of ADCs 8:36 - ADCs allow for more targeted cancer treatment 10:44 - How are ADCs structured? 14:16 - How do scientists find the best ADC combinations? 18:27 - Developing oncology drugs 22:02 - ADCs and bladder cancer 24:28 - A caregiver’s perspective on cancer treatment 38:12 - Science Will Win Season 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios. Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

18/11/2025

•

41 min
16/04/2025 · BONUS

Live from SXSW - How to Leverage Digital Tools to Become an Empowered Patient

Over the last five years, the healthcare industry has witnessed an explosive surge in digital health services, revolutionizing the way we access medical care. Patients today are taking charge of their health journey by using different digital tools to stay on top of their preventative screenings, implement dietary and lifestyle changes, access mental health resources, and so much more. In this conversation, patient advocates and industry leaders from Noom, Thrive, and Pfizer, dive into the potential power of artificial intelligence and the anticipated transformation in personalized health plans. They share real-world examples that highlight how digital technologies are helping patients feel empowered and shape the future of healthcare.  Through this conversation you heard Lidia Fonseca reference Health Answers by Pfizer. In February 2025, the Pfizer team launched this new platform, powered by generative AI that provides clear, relevant answers to your health & wellness questions and helps you take action for yourself and your loved ones. To learn more, visit healthanswers.pfizer.com. Moderator: Stephanie Agresta, Managing Director, Ascendancy Events  Featured experts: -Karin Bilich, Head of Content, Noom  -Lidia Fonseca, Chief Digital & Technology Officer, Pfizer  -MT Grant, SVP & GM, Thrive for Health This episode was recorded live in Austin, TX on Monday, March 10, as part of Pfizer’s takeover of the South by Southwest podcasting lounge. Please fill out our short survey so we can get to know our listeners better: pfizer.com/podcastsurvey Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

16/04/2025 · Bonus

•

59 min
08/10/2025

Gaining independence with haemophilia

To kick off season 2, our panel explores the impact that haemophilia has on patients and their families and the scientific progress being made to enable people with haemophilia to lead more independent lives. Our host Dr Ellie Cannon is joined by Kate Burt, Chief Executive at The Haemophilia Society, and Seema Patel, Specialty Care Medical Director at Pfizer UK. PP-UNP-GBR-13338 / September 2025 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

08/10/2025

•

35 min
11/11/2025

Part 3 — Getting Attached to Molecular Glues

Protein-protein interactions facilitate numerous bodily processes – everything from the basics of how our muscles contract to the more complex ways cancer can spread through the body. So, what if there was a way to alter some of these interactions? Or even create new ones? In this episode, we’re diving into the fascinating field of molecular glues, a revolutionary modality on the precipice of changing the treatment landscape for certain cancers and potentially other diseases and conditions. Featured Guests: – Joyann Donaldson, Principal Scientist, Synthesis Group Lead, Pfizer – Jennifer LaFontaine, Head of Oncology Medicinal Chemistry, Pfizer – Neal Sach, Research Fellow, Pfizer – Jillian Spangler, Associate Research Fellow, Pfizer Dive into the episode here: 0:50 - A metaphor to explain molecular glues 2:36 - How do molecular glues work in the body? 5:57 - A new frontier for cancer treatment 13:05 - The history behind molecular glues 16:59 - How do scientists design molecular glues? 19:05 - A visit to Pfizer’s La Jolla labs 32:42 - How can molecular glues change the patient experience? 36:42 - Molecular glues beyond cancer treatment Season 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios. Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

11/11/2025

•

40 min
16/04/2025 · BONUS

Live from SXSW - Outdoing Cancer Is A Team Sport

While cancer deaths in the United States have declined in recent years, some populations are being left behind—facing complicated challenges to accessing the care they need. Intervening at the earliest stages of disease onset is critical to cancer treatment success and to reducing the risk of recurrence. So how do we create a world where all people with cancer are quickly diagnosed and can live better, longer lives as science advances? In this conversation, patient advocates and healthcare leaders from Pfizer, the American Cancer Society, and the Healthcare Businesswomen’s Association, discuss the power of collaboration in the effort to “Outdo Cancer.” Moderator • Tyrone McClain, Senior Director, Public Affairs, Pfizer Speakers • Carmen White, U.S. & Global Oncology Health Equity Lead, Pfizer • Pam Traxel, American Cancer Society, Cancer Action Network • Mary Stutts, CEO, Healthcare Businesswomen's Association (HBA) This episode was recorded live in Austin, TX on Monday, March 10, as part of Pfizer’s takeover of the South by Southwest podcasting lounge. Please fill out our short survey so we can get to know our listeners better: pfizer.com/podcastsurvey Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

16/04/2025 · Bonus

•

58 min
10/12/2019

Vaccines 101

Vaccines have saved millions of lives, but they’ve also become victims of their own success. They’ve done such a good job that we’ve forgotten what serious infections like polio and diphtheria look like. On the first episode of The Antigen, host Yasmeen Agosti takes us through vaccine basics with the help of experts Dr. Kathryn Edwards, Dr. Peter Hotez, Martha Rebour, LJ Tan, and Serese Marotta, who explain why vaccines are more relevant now than ever.

10/12/2019

•

23 min
18/02/2025

Part 2 – How Video Games Helped Pave the Way for AI in Medicine

Last episode discussed data and how crucial large swaths of data are in assisting drug development. But more data requires a lot of storage – and that’s where hardware comes in. To make use of big data and all its possibilities, scientists need new tools at their disposal. In this episode, host Jeremiah Owyang, alongside expert guests, traces the rise of large-scale computational resources used throughout the medical industry today. Featured Guests: –Daniel Ziemek, Vice President of Integrative Biology and Systems Immunology at Pfizer –Enoch Huang, Head of Machine Learning and Computational Sciences at Pfizer –Tor Aamodt, professor at the University of British Columbia Season 4 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

18/02/2025

•

23 min

Go behind the breakthroughs and explore the stories of the work we do at Pfizer around the globe, in conversations with the scientists and leaders who make it happen. Listen to recent episodes and follow along.